http://dailynews.yahoo.com/h/nm/20010620/hl/vaccine_1.html
Wednesday June 20 10:22 AM ET
By Michael Byrnes
SYDNEY (Reuters) - Australian scientists say they have scored a world
breakthrough by developing a vaccine to make plants immune to viruses. Because
of how it works, they say, the vaccine sidesteps consumer concerns about
genetically modified food.
The vaccine could increase yields of major crops such as wheat and barley by
up to 30% by activating plant defense mechanisms to knock out diseases before
they take hold, in the same way a shot in the arm can protect humans from flu.
But unlike other forms of genetically modified (GM) food, rejected by many
consumers around the world, the Australian technique does not change plants by
inserting a foreign gene. It simply silences an existing gene.
``From that point of view it's perhaps more acceptable to consumers,''
scientist Peter Waterhouse said on Wednesday. ``It's very exciting. It's
enabling technology, you can do all sorts of different things with it.''
The vaccine could be used to knock out plant genes to produce non-browning
bananas, caffeine-free coffee and many other changes in plants that do not
involve altering their protein structure, said Waterhouse, a scientist with the
government's Commonwealth Scientific and Industrial Research Organization
(CSIRO).
The technique can also silence unwanted genes that produce allergens in nuts
or pollen.
TECHNOLOGY READY TO ROLL
The technology, recently proven in barley plants raised in greenhouses and
about to be used in trial crops, involves inserting a small, incomplete piece
of virus RNA into plant DNA.
DNA, or deoxyribonucleic acid, is the material from which genes--which transmit
hereditary characteristics--are made. RNA, or ribonucleic acid, helps cells
make proteins, and is also the hereditary material in some viruses.
The plant recognizes the virus RNA as foreign and activates its defense
mechanism, degrading the invader before it multiplies.
This results in immunity to the virus, which scientists say can be passed
down through plant generations.
When the breakthrough will be brought to market is complicated by
cross-patent negotiations with multinational corporations active in the GM
business, as well as by consumer reaction. But technologically the process is
ready to roll.
``From a technical point of view there's nothing stopping us getting plants
that would be ready to be commercialized,'' Waterhouse told Reuters.
The technology is likely to be commercialized first in a proven process
which switches off unwanted genes in cottonseed, producing ``healthier''
cooking oil, he said.This is three to five years away from commercialization,
research team leader Allan Green told Reuters on Wednesday.
The CSIRO team has also already developed potatoes resistant to potato leaf
roll virus using the technique, with plants tested in laboratories, glasshouses
and in field trials.
Waterhouse said the vaccination technology would be worth millions, if not
billions, of dollars in license fees and increased productivity.
HUGE SAVINGS SEEN
Savings to Australia's big wheat crop alone, worth around A$4 billion a year
on world markets (about $2 billion US), would be huge.
Multinationals would have to buy licenses from the CSIRO if they wanted to
use the technology, which was in the process of being patented, he said.
Hundreds of international laboratories had already requested technical details.
``It's a technology everyone wants to use.''
CSIRO's biggest breakthrough with the new technique has come with successful
trials to knock out the major world-wide crop disease barley yellow dwarf virus
(BYDV), which affects Australia's wheat, barley and oats crops.
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.